glp 1 alcohol GLP-1 Therapeutics and Their Emerging Role in and Substance Use Disorders: An Endocrinology Primer IUPHAR review – Glucagon-like peptide-1
Description
British J
And its funny, I was talking about this on a different podcast a couple of weeks ago
Non-alcoholic fatty liver disease, now termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects approximately one in three UK adults
Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus
